compliance issues reimbursing glp-1 weight loss treatments multiple states coverage for obesity treatment in 13 US states' Medicaid programs Who Gets the Shot? GLP-1

Given the heterogeneity of the included evidencespanning case reports, pharmacovigilance analyses, and observational cohortsthis review is framed primarily as a signal-detection and evidence-mapping exercise rather than a causal-inference analysis

GLP-1 works best with nutrition support

Semaglutide increased mean %EWL in WR patients from 34 to 68% by year 3

They suppress post-prandial glucagon release, delay stomach emptying, and increase insulin sensitivity

Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.

Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.